SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Huvudupphovsman: | Meem, Manila |
---|---|
Övriga upphovsmän: | Akter, Dr. Raushanara |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2023
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/18081 |
Liknande verk
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
av: Islam, Saidul
Publicerad: (2022) -
RIPK pathway, as a potential target, for cancer treatment - a review
av: Jahan, Nusrat
Publicerad: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Flora, Sanzida Alam
Publicerad: (2024) -
Immunotherapy in the Management of Lung Cancer
av: Tasnim, Humayra
Publicerad: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
av: Ratu, Tabassum
Publicerad: (2024)